Encision Inc. (ECIA)
OTCMKTS · Delayed Price · Currency is USD
0.3600
0.00 (0.00%)
Oct 6, 2025, 8:00 PM EDT
Encision Market Cap
Encision has a market cap or net worth of $5.73 million as of October 8, 2025. Its market cap has decreased by -2.21% in one year.
Market Cap
5.73M
Enterprise Value
7.52M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.36
Market Cap Chart
Since August 13, 1996, Encision's market cap has decreased from 46.95M to 5.73M, a decrease of -87.79%. That is a compound annual growth rate of -6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 5.73M | 7.26% |
| Dec 23, 2024 | 5.34M | 6.83% |
| Dec 29, 2023 | 5.00M | -14.97% |
| Dec 30, 2022 | 5.88M | -66.20% |
| Dec 31, 2021 | 17.40M | 249.40% |
| Dec 31, 2020 | 4.98M | 2.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 274.14M |
| Silence Therapeutics | 242.78M |